Abstract | OBJECTIVE: To assess the importance of normalizing bladder capacity to the age-expected capacity in children with refractory monosymptomatic nocturnal enuresis (MNE), and to evaluate the long-term results when these children grow into adolescence. PATIENTS AND METHODS: The study included 34 children with refractory MNE; all were treated > 5 years earlier for their MNE using a combined stepwise approach, consisting of retention control training, oxybutynin and an enuresis alarm. Data were obtained on their enuretic state, night-time voiding behaviour and bladder capacity, from a questionnaire and a voiding chart. RESULTS: Before starting treatment, all patients had a bladder capacity that was too small for their age. After the combined stepwise approach, MNE improved in all patients and 24 (71%) were cured. Although the bladder capacity was increased to the age-expected capacity in 26 (76%), most woke at night to void. Currently, at a mean of 7.7 years after the primary treatment, 28 (82%) of the patients are completely dry at night, of whom 15 (54%) arouse to void for 35% of the nights. Six patients (18%) still have some enuretic episodes. Only those who were dry after primary treatment and remained dry had a normal age-expected increase in bladder capacity. For all others there was a decrease in age-related bladder capacity. CONCLUSIONS: In patients with refractory MNE, a combined stepwise approach improves and may even eliminate enuresis, but normal night-time bladder behaviour in adolescence and adulthood is only achieved in some. Furthermore, about a fifth still have some enuretic episodes.
|
Authors | Alexandra Vermandel, Stefan de Wachter, Jean-Jacques Wyndaele |
Journal | BJU international
(BJU Int)
Vol. 96
Issue 4
Pg. 629-33
(Sep 2005)
ISSN: 1464-4096 [Print] England |
PMID | 16104923
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Cholinergic Antagonists
- Mandelic Acids
- oxybutynin
|
Topics |
- Adolescent
- Biofeedback, Psychology
- Child
- Child, Preschool
- Cholinergic Antagonists
(therapeutic use)
- Combined Modality Therapy
- Enuresis
(drug therapy, pathology, therapy)
- Female
- Follow-Up Studies
- Humans
- Male
- Mandelic Acids
(therapeutic use)
- Physical Therapy Modalities
- Prospective Studies
- Treatment Outcome
- Urinary Bladder
(pathology)
- Urination
|